Information Provided By:
Fly News Breaks for March 4, 2020
UNH
Mar 4, 2020 | 07:35 EDT
After hosting investor meetings with management, Citi analyst Ralph Giacobbe believes the financial impact from the coronavirus has been limited for UnitedHealth. Beyond that, the company's underlying cost trends remain well managed, Giacobbe tells investors in a research note. This coupled with Medicare Advantage continuing to show solid growth, Medicaid positioned to improve in 2020, and opportunities across Optum "should all allow strong growth to continue this year," says the analyst, who reiterates a Buy rating on UnitedHealth.
News For UNH From the Last 2 Days
UNH
Mar 28, 2024 | 15:22 EDT
What has Wall Street been buzzing about this week? Here are the top 5 Bu-y calls and the top 5 Sell calls made by Wall Street’s best analysts during the week of March 25-28. Find all top-rated... To see the rest of the story go to thefly.com. See Story Here
UNH
Mar 28, 2024 | 06:51 EDT
BofA downgraded Molina Healthcare (MOH) to Underperform from Neutral with a $439 price target. The firm, which is concerned that Molina and the Medicaid industry more broadly are likely to face rate pressure after a period of elevated margins, sees a less attractive risk/reward for Molina compared to other insurers the firm covers, the analyst tells investors. Molina is now trading roughly at parity with the firm's top pick in the space, UnitedHealth (UNH), compared to a 22% discount that had been seen over the last five years, helping to underscore the firm's view that "sentiment for Medicaid is nearing a top just at a time when Medicare is reaching a bottom," the analyst added.